Clovis Oncology (CLVS) - NASDAQ
Company Description
Clovis Oncology, Inc. is a biopharmaceutical company which focuses on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. The company has three product candidates in its clinical development pipeline: Rociletinib, Rucaparib... More
Sector: Healthcare
Industry: Biotechnology
Country: United States